These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 39132849)

  • 1. Spatial and temporal patterns of cortical mean diffusivity in Alzheimer's disease and suspected non-Alzheimer's disease pathophysiology.
    Sun P; He Z; Li A; Yang J; Zhu Y; Cai Y; Ma T; Ma S; Guo T;
    Alzheimers Dement; 2024 Oct; 20(10):7048-7061. PubMed ID: 39132849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of cortical microstructure with amyloid-β and tau: impact on cognitive decline, neurodegeneration, and clinical progression in older adults.
    Rodriguez-Vieitez E; Montal V; Sepulcre J; Lois C; Hanseeuw B; Vilaplana E; Schultz AP; Properzi MJ; Scott MR; Amariglio R; Papp KV; Marshall GA; Fortea J; Johnson KA; Sperling RA; Vannini P
    Mol Psychiatry; 2021 Dec; 26(12):7813-7822. PubMed ID: 34588623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of quantitative susceptibility mapping with Alzheimer's disease clinical and imaging markers.
    Cogswell PM; Wiste HJ; Senjem ML; Gunter JL; Weigand SD; Schwarz CG; Arani A; Therneau TM; Lowe VJ; Knopman DS; Botha H; Graff-Radford J; Jones DT; Kantarci K; Vemuri P; Boeve BF; Mielke MM; Petersen RC; Jack CR
    Neuroimage; 2021 Jan; 224():117433. PubMed ID: 33035667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linking white matter hyperintensities to regional cortical thinning, amyloid deposition, and synaptic density loss in Alzheimer's disease.
    Zhang J; Chen H; Wang J; Huang Q; Xu X; Wang W; Xu W; Guan Y; Liu J; Wardlaw JM; Deng Y; Xie F; Li B
    Alzheimers Dement; 2024 Jun; 20(6):3931-3942. PubMed ID: 38648354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology.
    Schreiber S; Schreiber F; Lockhart SN; Horng A; Bejanin A; Landau SM; Jagust WJ;
    JAMA Neurol; 2017 Jun; 74(6):650-659. PubMed ID: 28319241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visual cognition in non-amnestic Alzheimer's disease: Relations to tau, amyloid, and cortical atrophy.
    Putcha D; Brickhouse M; Touroutoglou A; Collins JA; Quimby M; Wong B; Eldaief M; Schultz A; El Fakhri G; Johnson K; Dickerson BC; McGinnis SM
    Neuroimage Clin; 2019; 23():101889. PubMed ID: 31200149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study.
    Burnham SC; Bourgeat P; Doré V; Savage G; Brown B; Laws S; Maruff P; Salvado O; Ames D; Martins RN; Masters CL; Rowe CC; Villemagne VL;
    Lancet Neurol; 2016 Sep; 15(10):1044-53. PubMed ID: 27450471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early Cortical Microstructural Changes in Aging Are Linked to Vulnerability to Alzheimer's Disease Pathology.
    Tang R; Franz CE; Hauger RL; Dale AM; Dorros SM; Eyler LT; Fennema-Notestine C; Hagler DJ; Lyons MJ; Panizzon MS; Puckett OK; Williams ME; Elman JA; Kremen WS
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2024 Oct; 9(10):975-985. PubMed ID: 38878863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measures of cortical microstructure are linked to amyloid pathology in Alzheimer's disease.
    Spotorno N; Strandberg O; Vis G; Stomrud E; Nilsson M; Hansson O
    Brain; 2023 Apr; 146(4):1602-1614. PubMed ID: 36130332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterizing brain tau and cognitive decline along the amyloid timeline in Alzheimer's disease.
    Cody KA; Langhough RE; Zammit MD; Clark L; Chin N; Christian BT; Betthauser TJ; Johnson SC
    Brain; 2024 Jun; 147(6):2144-2157. PubMed ID: 38667631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Astrocyte reactivity is associated with tau tangle load and cortical thinning in Alzheimer's disease.
    Guo T; Li A; Sun P; He Z; Cai Y; Lan G; Liu L; Li J; Yang J; Zhu Y; Zhao R; Chen X; Shi D; Liu Z; Wang Q; Xu L; Zhou L; Ran P; Wang X; Sun K; Lu J; Han Y
    Mol Neurodegener; 2024 Jul; 19(1):58. PubMed ID: 39080744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of common reference regions on regional tau patterns in cross-sectional and longitudinal [
    Young CB; Landau SM; Harrison TM; Poston KL; Mormino EC;
    Neuroimage; 2021 Nov; 243():118553. PubMed ID: 34487825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity in Suspected Non-Alzheimer Disease Pathophysiology Among Clinically Normal Older Individuals.
    Mormino EC; Papp KV; Rentz DM; Schultz AP; LaPoint M; Amariglio R; Hanseeuw B; Marshall GA; Hedden T; Johnson KA; Sperling RA
    JAMA Neurol; 2016 Oct; 73(10):1185-1191. PubMed ID: 27548655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unveiling the link between glymphatic function and cortical microstructures in post-traumatic stress disorder.
    Shao Z; Gao X; Cen S; ; Tang X; Gong J; Ding W
    J Affect Disord; 2024 Nov; 365():341-350. PubMed ID: 39178958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid Beta-Weighted Cortical Thickness: A New Imaging Biomarker in Alzheimer's Disease.
    Kim CM; Hwang J; Lee JM; Roh JH; Lee JH; Koh JY;
    Curr Alzheimer Res; 2015; 12(6):563-71. PubMed ID: 26027813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between tau, Aβ, and cortical thickness with cognition in Alzheimer disease.
    Ossenkoppele R; Smith R; Ohlsson T; Strandberg O; Mattsson N; Insel PS; Palmqvist S; Hansson O
    Neurology; 2019 Feb; 92(6):e601-e612. PubMed ID: 30626656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rates of cortical thinning in Alzheimer's disease signature regions associate with vascular burden but not with β-amyloid status in cognitively normal adults at age 70.
    Keuss SE; Coath W; Cash DM; Barnes J; Nicholas JM; Lane CA; Parker TD; Keshavan A; Buchanan SM; Wagen AZ; Storey M; Harris M; Lu K; James SN; Street R; Malone IB; Sudre CH; Thomas DL; Dickson JC; Barkhof F; Murray-Smith H; Wong A; Richards M; Fox NC; Schott JM
    J Neurol Neurosurg Psychiatry; 2024 Jul; 95(8):748-752. PubMed ID: 38199813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inferior temporal tau is associated with accelerated prospective cortical thinning in clinically normal older adults.
    Scott MR; Hampton OL; Buckley RF; Chhatwal JP; Hanseeuw BJ; Jacobs HI; Properzi MJ; Sanchez JS; Johnson KA; Sperling RA; Schultz AP
    Neuroimage; 2020 Oct; 220():116991. PubMed ID: 32512123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease.
    Maass A; Landau S; Baker SL; Horng A; Lockhart SN; La Joie R; Rabinovici GD; Jagust WJ;
    Neuroimage; 2017 Aug; 157():448-463. PubMed ID: 28587897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spatial extent as a sensitive amyloid-PET metric in preclinical Alzheimer's disease.
    Farrell ME; Thibault EG; Becker JA; Price JC; Healy BC; Hanseeuw BJ; Buckley RF; Jacobs HIL; Schultz AP; Chen CD; Sperling RA; Johnson KA
    Alzheimers Dement; 2024 Aug; 20(8):5434-5449. PubMed ID: 38988055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.